Medically reviewed by Mary Choy, PharmDJoint pain can be caused by a number of biological, psychological, and social factors.

Averitas Pharma, the US subsidiary of Grünenthal, has completed patient recruitment for the Phase III AV001 clinical study, ...

Cannabidiol (CBD) holds great promise as a treatment for many health concerns, including inflammation. For all the known benefits CBD offers, it’s unclear how well it can relieve nerve pain.

Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...

Neuropathic pain is a severe clinical condition caused by damage to the nervous system. It often feels like a burning, ...

Groundbreaking research has transformed our understanding of acupuncture's role in treating sciatica, a debilitating ...

Traditional withdrawal treatments don't work for the animal tranquilizer xylazine, which is everywhere in Phlly's drug supply ...

The FDA has placed a trial of Rapport Therapeutics’ epilepsy drug for a type of nerve pain on hold while the biotech tweaks ...

ITDD helps effectively manage chronic pain and spasticity in some patients but requires adherence to best practices and a ...

Chromocell Therapeutics (CHRO) announced the unveiling of its injectable depot program utilizing peripheral nerve blocks for the treatment of ...

Boston Children's Hospital and Harvard Medical School researchers have discovered a neuroimmune communication pathway that ...